Apellis Pharmaceuticals Inc (APLS) reports significant revenue growth driven by SYFOVRE, while navigating market challenges ...

Rich in history, the luxury country bolthole has a plethora of elegant rooms — everything from cosy romantic classics to opulent suites. The Retreat at Matfen Hall has expert therapists eager to ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® ...

Alt-rockers The Beta Band have spoken of their excitement at getting back together for a reunion tour across the UK and USA ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® (pegcetacopl ...

Book bespoke experiences such as private cruises, speedboat transfers and beachside dinners and sample new Mediterranean and Asian-inspired menus, complemented by expertly crafted cocktails and ...

Credit: NASA/Johns Hopkins APL/Steve Gribben Strange things are afoot ... The drone will carry cameras, a drill to sample surface ice, and a suite of instruments to identify molecules in the ...

In the remote village of Badhal, Jammu and Kashmir, a mysterious illness has claimed 17 lives, including 13 children, over a two-month period. Despite forensic confirmation of neurotoxic exposure, ...

The document builds on the academies' decadal survey, outlining recommended missions for NASA's next New Frontiers program.

Axis Securities suggested a 'Buy' and a target of Rs 710. On APL Apollo Tubes, it sees Ebitda per tonne rebounding, as demand normalises. The brokerage suggested a target of Rs 1,750. For Tata ...